Loading...
•
Dec 31, 2023
LifeStance Q4 2023 Earnings Report
LifeStance reported a 22% increase in Q4 revenue, driven by clinician growth, visit volumes, and revenue per visit.
Key Takeaways
LifeStance Health Group, Inc. announced its Q4 2023 financial results, featuring a 22% increase in revenue to $280.6 million. The company's clinician base grew by 18%, with visit volumes up by 20%. Despite a net loss of $45.0 million, adjusted EBITDA was positive at $20.3 million. The company is focused on operational improvements and profitable growth.
Q4 revenue increased by 22% to $280.6 million.
Clinician base increased by 18% to 6,645 clinicians.
Visit volumes increased by 20% to 1.8 million.
Adjusted EBITDA increased 99% to $20.3 million.
Forward Guidance
LifeStance expects full year 2024 revenue of $1.19 billion to $1.24 billion, Center Margin of $345 to $365 million, Adjusted EBITDA of $80 to $90 million, and positive Free Cash Flow.
Positive Outlook
- Expecting full year 2024 revenue of $1.19 billion to $1.24 billion
- Center Margin of $345 to $365 million
- Adjusted EBITDA of $80 to $90 million
- Expecting positive Free Cash Flow for the full year
- Focus on operational improvements, profitable growth, and disciplined capital deployment
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...